ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,346.51
1.66%
Brent Oil
83.95
0.47%
Bitcoin
62,625.08
2.35%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) News

BioPharmX (BPMX)

BioPharmX Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:BPMX
DateTimeSourceHeadlineSymbolCompany
29/05/202011:04Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
28/05/202022:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
27/05/202022:23Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
22/05/202022:17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
19/05/202021:41GlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
15/05/202021:36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
15/05/202021:05PR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
13/05/202021:33Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
13/05/202021:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
13/05/202021:05PR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
11/05/202021:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
11/05/202021:09Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
08/05/202014:00PR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
07/05/202011:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
27/04/202021:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
27/04/202021:13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
27/04/202021:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
27/04/202021:05PR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
06/04/202021:55Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
06/04/202021:53Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
06/04/202021:30PR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
01/04/202021:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
01/04/202011:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
30/03/202021:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
30/03/202021:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
30/03/202011:17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
25/03/202020:15PR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
23/03/202020:24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/02/202011:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
18/02/202021:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Your Recent History

LSE
TERN
Tern
LSE
POS
Plexus
LSE
SCE
Surface Transforms
LSE
BIRD
Blackbird
LSE
KEFI
Kefi Gold And Copper
LSE
GOLD
LSE
SYME
Supply@me Capital
LSE
AGL
Angle
LSE
ITV
Itv
LSE
GCM
Gcm Resources
LSE
PET
Petrel Resources
LSE
BOO
Boohoo
LSE
SAR
Sareum
LSE
GDR
Genedrive
LSE
GWMO
Great Western Mining
LSE
GFM
Griffin Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved